NCT04875286View on ClinicalTrials.gov

Patient Reported Symptom Control With THC or CBD Use

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Cancer-Associated PainHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Electronic Health Record Review

Medical records reviewed

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (2)

77030

M D Anderson Cancer Center, Houston

85234

Banner MD Anderson Cancer Center, Gilbert

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER